P2.02 Second-line Afatinib vs Erlotinib for Advanced Lung Squamous Cell Carcinoma: Final Analysis of the Phase 3 LUX-Lung 8 Trial

Journal of Thoracic Oncology(2019)

引用 0|浏览118
暂无评分
关键词
lung SCC,afatinib,erlotinib,second-line
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要